次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

再生医療用コラーゲンおよびゼラチンの世界市場:2022年に至る由来原料別、用途別予測

Collagen & Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis - Global Forecast to 2022

出版元:MarketsandMarketsLinkIcon出版元について
発行年:2017年8月
定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文 180ページになります。
商品コード:MAM713

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
再生医療用コラーゲンの世界市場規模は2017年段階の4億2060万ドルから2022年に6億7990万ドル、また再生医療用ゼラチンの世界市場は、2017年の6520万ドルから2022年には9490万ドル規模へ拡大すると、レポートでは予測しています。
当レポートでは、2022年に至る再生医療用コラーゲン及びゼラチンの世界市場予測(市場規模US$、量ベース:コラーゲンKilogram、ゼラチンTon )、再生医療用コラーゲン市場(由来原料別、用途別)、再生医療用ゼラチン市場 (由来原料別、用途別)、主要国地域別市場など、詳細な市場予測データと分析を掲載しています。また市場分析、競合状況、主要メーカー企業10社プロフィール動向などの情報も交えて、再生医療用コラーゲン及びゼラチン市場の現在と今後展開を予測分析していきます。

【レポート構成概要】pic04_pharma.jpg
◆ 再生医療用コラーゲン及びゼラチンの世界市場予測2015-2022年
・市場規模(US$)
・量ベース(コラーゲン:Kilogram、ゼラチン:Ton)

◆ 再生医療用コラーゲン市場、由来原料別-2022年
・牛コラーゲン
・豚コラーゲン
・マリンコラーゲン
・その他ソース
※(市場規模US$、量ベースKilogram)

◆ 再生医療用ゼラチン市場、由来原料別-2022年
・牛ゼラチン
・豚ゼラチン
・その他ソース
※(市場規模US$、量ベースTon)

◆ 再生医療用コラーゲン市場、用途別-2022年
・創傷ケア
・整形外科用
・心血管系
・その他用途
※(市場規模US$、量ベースKilogram)

◆ 再生医療用ゼラチン市場、用途別-2022年
・創傷ケア
・整形外科用
・心臓血管、胸部
・その他用途
※(市場規模US$、量ベースTon)

◆主要国地域別市場-2022年
北米
・米国、カナダ
欧州
・EUROPE-5(英国、ドイツ、フランス、スペイン、イタリア:五か国合算)
・その他欧州
アジア太平洋
・日本、インド、中国
・その他アジア太平洋
その他地域
※ 国地域別に全てのセグメントの細分化データ掲載、詳細は目次参照
※(市場規模US$、量ベース:コラーゲンKilogram、ゼラチンTon)

◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会)
・競合状況

◆ 再生医療用コラーゲン及びゼラチンの主要企業プロフィール動向
・INTEGRA LIFESCIENCES HOLDINGS CORPORATION
・COLLAGEN MATRIX, INC.
・COLLAGEN SOLUTIONS PLC
・ROYAL DSM
・VORNIA BIOMATERIALS, LTD.
・SYMATESE
・NUCOLLAGEN, LLC.
・GELITA AG
・新田ゼラチン株式会社.
・PB GELATIN

(全180貢)
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Collagen & Gelatin Market for Regenerative Medicine (by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular)), Value and Volume Analysis - Global Forecast to 2022

Table of Contents

1 INTRODUCTION 17

1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20

2.1.1 RESEARCH METHODOLOGY STEPS 20
2.1.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 21
2.1.2.1 Secondary research 21
2.1.3 KEY DATA FROM SECONDARY SOURCES 21
2.1.3.1 Primary research 22
2.1.4 MARKET SIZE ESTIMATION METHODOLOGY 25
2.1.5 MARKET FORECAST METHODOLOGY 28
2.1.6 MARKET DATA VALIDATION AND TRIANGULATION 29
2.1.7 ASSUMPTIONS FOR THE STUDY 30

3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 36

4.1 COLLAGEN MARKET FOR REGENERATIVE MEDICINE: MARKET OVERVIEW 36
4.2 GELATIN MARKET FOR REGENERATIVE MEDICINE: MARKET OVERVIEW 37
4.3 GLOBAL COLLAGEN MARKET SIZE FOR REGENERATIVE MEDICINE,
BY SOURCE, 2017 VS. 2022 37
4.4 GLOBAL GELATIN MARKET SIZE FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2017 VS. 2022 38
4.5 GEOGRAPHIC SNAPSHOT OF THE GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE 38
4.6 GEOGRAPHIC SNAPSHOT OF THE GLOBAL GELATIN MARKET FOR
REGENERATIVE MEDICINE 39

5 MARKET OVERVIEW 40

5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Availability of Government and Private Funding for R&D 42
5.2.1.2 Rising Prevalence of Chronic Diseases 42
5.2.1.3 Rapid Growth in Aging Population 42
5.2.2 RESTRAINTS 43
5.2.2.1 Availability of Alternate Biomaterials 43
5.2.3 OPPORTUNITIES 44
5.2.3.1 Increasing Research on Collagen and Gelatin-based Products 44

6 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE 45

6.1 INTRODUCTION 46
6.2 BOVINE COLLAGEN 47
6.3 PORCINE COLLAGEN 48
6.4 MARINE COLLAGEN 49
6.5 OTHER SOURCES 51

7 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE 52

7.1 INTRODUCTION 53
7.2 BOVINE GELATIN 54
7.3 PORCINE GELATIN 55
7.4 OTHER SOURCES 56

8 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 58

8.1 INTRODUCTION 59
8.2 ORTHOPEDIC APPLICATIONS 60
8.3 WOUND CARE 62
8.4 CARDIOVASCULAR APPLICATIONS 63
8.5 OTHER APPLICATIONS 64

9 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 66

9.1 INTRODUCTION 67
9.2 WOUND CARE 68
9.3 ORTHOPEDIC APPLICATIONS 69
9.4 CARDIOVASCULAR AND THORACIC APPLICATIONS 70
9.5 OTHER APPLICATIONS 72

10 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION 73

10.1 INTRODUCTION 74
10.2 NORTH AMERICA 76
10.2.1 U.S. 79
10.2.2 CANADA 82
10.3 EUROPE 85
10.3.1 EUROPE-5 88
10.3.2 REST OF EUROPE (ROE) 91
10.4 ASIA-PACIFIC 94
10.4.1 JAPAN 99
10.4.2 INDIA 101
10.4.3 CHINA 103
10.4.4 ROAPAC 105
10.5 REST OF THE WORLD (ROW) 106

11 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION 110

11.1 INTRODUCTION 111
11.2 NORTH AMERICA 113
11.2.1 U.S. 116
11.2.2 CANADA 119
11.3 EUROPE 122
11.3.1 EUROPE-5 125
11.3.2 REST OF EUROPE 127
11.4 ASIA-PACIFIC 130
11.4.1 JAPAN 134
11.4.2 INDIA 136
11.4.3 CHINA 138
11.4.4 ROAPAC 140
11.5 REST OF THE WORLD (ROW) 142

12 COMPETITIVE LANDSCAPE 146

12.1 OVERVIEW 146
12.2 COMPETITIVE SITUATION AND TRENDS 147
12.3 AGREEMENTS, COLLABORATIONS, AND CONTRACTS 148
12.4 ACQUISITIONS 149
12.5 APPROVALS 150
12.6 OTHER STRATEGIES 151

13 COMPANY PROFILE 153

(OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS.)*
13.1 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 153
13.2 COLLAGEN MATRIX, INC. 156
13.3 COLLAGEN SOLUTIONS PLC 158
13.4 ROYAL DSM 161
13.5 VORNIA BIOMATERIALS, LTD. 163
13.6 SYMATESE 164
13.7 NUCOLLAGEN, LLC. 165
13.8 GELITA AG 166
13.9 NITTA GELATIN INC. 167
13.10 PB GELATIN 168
*Details on Overview, Recent Developments, Key relationships might not be captured in case of unlisted companies.
14 APPENDIX 169

LIST OF TABLES

TABLE 1 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015-2022 (USD MILLION) 46
TABLE 2 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015-2022 (KILOGRAMS) 47
TABLE 3 BOVINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 48
TABLE 4 BOVINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 48
TABLE 5 PORCINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 49
TABLE 6 PORCINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 49
TABLE 7 MARINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 50
TABLE 8 MARINE COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 50
TABLE 9 OTHER COLLAGENS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 51
TABLE 10 OTHER COLLAGENS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (KILOGRAMS) 51
TABLE 11 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015-2022 (USD MILLION) 53
TABLE 12 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015-2022 (TONS) 54
TABLE 13 BOVINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 54
TABLE 14 BOVINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (TONS) 55
TABLE 15 PORCINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 55
TABLE 16 PORCINE GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (TONS) 56
TABLE 17 OTHER GELATINS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (USD MILLION) 56
TABLE 18 OTHER GELATINS MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015-2022 (TONS) 57
TABLE 19 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (USD MILLION) 59
TABLE 20 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (KILOGRAMS) 60
TABLE 21 COMMERCIALLY AVAILABLE COLLAGEN SCAFFOLDS FOR BONE REGENERATION 60
TABLE 22 ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION) 61
TABLE 23 ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS) 61
TABLE 24 WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION) 62
TABLE 25 WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS) 63
TABLE 26 CARDIOVASCULAR APPLICATIONS MARKET, BY REGION,
2015-2022 (USD MILLION) 63
TABLE 27 CARDIOVASCULAR APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS) 64
TABLE 28 OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION) 64
TABLE 29 OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (KILOGRAMS) 65
TABLE 30 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (USD MILLION) 67
TABLE 31 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015-2022 (TONS) 68
TABLE 32 WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION) 68
TABLE 33 WOUND CARE APPLICATIONS MARKET, BY REGION, 2015-2022 (TONS) 69
TABLE 34 ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION) 70
TABLE 35 ORTHOPEDIC APPLICATIONS MARKET, BY REGION, 2015-2022 (TONS) 70
TABLE 36 CARDIOVASCULAR AND THORACIC APPLICATIONS MARKET, BY REGION,
2015-2022 (USD MILLION) 71
TABLE 37 CARDIOVASCULAR AND THORACIC APPLICATIONS MARKET, BY REGION,
2015-2022 (TONS) 71
TABLE 38 OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION) 72
TABLE 39 OTHER APPLICATIONS MARKET, BY REGION, 2015-2022 (TONS) 72
TABLE 40 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 75
TABLE 41 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (KILOGRAMS) 75
TABLE 42 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2015–2022 (USD MILLION) 77
TABLE 43 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY COUNTRY, 2015–2022 (KILOGRAMS) 77
TABLE 44 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY SOURCE, 2015–2022 (USD MILLION) 77
TABLE 45 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY SOURCE, 2015–2022 (KILOGRAMS) 78
TABLE 46 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (USD MILLION) 78
TABLE 47 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (KILOGRAMS) 79
TABLE 48 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 80
TABLE 49 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 80
TABLE 50 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 81
TABLE 51 U.S.: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (KILOGRAMS) 81
TABLE 52 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 82
TABLE 53 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 83
TABLE 54 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 83
TABLE 55 CANADA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 84
TABLE 56 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 86
TABLE 57 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (KILOGRAMS) 86
TABLE 58 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 87
TABLE 59 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 87
TABLE 60 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 88
TABLE 61 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 88
TABLE 62 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 89
TABLE 63 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 90
TABLE 64 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 90
TABLE 65 E-5: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (KILOGRAMS) 91
TABLE 66 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 92
TABLE 67 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 92
TABLE 68 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 93
TABLE 69 ROE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (KILOGRAMS) 93
TABLE 70 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 96
TABLE 71 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (KILOGRAMS) 96
TABLE 72 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (USD MILLION) 97
TABLE 73 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (KILOGRAMS) 97
TABLE 74 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (USD MILLION) 98
TABLE 75 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (KILOGRAMS) 98
TABLE 76 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 99
TABLE 77 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 99
TABLE 78 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 100
TABLE 79 JAPAN: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 100
TABLE 80 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 101
TABLE 81 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 101
TABLE 82 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 102
TABLE 83 INDIA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 102
TABLE 84 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 103
TABLE 85 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 103
TABLE 86 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 104
TABLE 87 CHINA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 104
TABLE 88 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 105
TABLE 89 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 105
TABLE 90 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 106
TABLE 91 ROAPAC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 106
TABLE 92 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 108
TABLE 93 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (KILOGRAMS) 108
TABLE 94 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 109
TABLE 95 ROW: COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (KILOGRAMS) 109
TABLE 96 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 112
TABLE 97 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2015–2022 (TONS) 112
TABLE 98 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 114
TABLE 99 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (TONS) 114
TABLE 100 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (USD MILLION) 115
TABLE 101 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (TONS) 115
TABLE 102 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (USD MILLION) 116
TABLE 103 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE,
BY APPLICATION, 2015–2022 (TONS) 116
TABLE 104 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 117
TABLE 105 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 118
TABLE 106 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 118
TABLE 107 U.S.: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 119
TABLE 108 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 120
TABLE 109 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 120
TABLE 110 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 121
TABLE 111 CANADA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 121
TABLE 112 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (USD MILLION) 123
TABLE 113 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY REGION,
2015–2022 (TONS) 123
TABLE 114 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 123
TABLE 115 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 124
TABLE 116 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 124
TABLE 117 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 125
TABLE 118 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 126
TABLE 119 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 126
TABLE 120 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 127
TABLE 121 E-5: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 127
TABLE 122 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 128
TABLE 123 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 128
TABLE 124 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 129
TABLE 125 ROE: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 129
TABLE 126 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (USD MILLION) 131
TABLE 127 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2015–2022 (TONS) 132
TABLE 128 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (USD MILLION) 132
TABLE 129 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE, 2015–2022 (TONS) 133
TABLE 130 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 133
TABLE 131 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 134
TABLE 132 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 134
TABLE 133 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 135
TABLE 134 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 135
TABLE 135 JAPAN: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 136
TABLE 136 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 136
TABLE 137 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 137
TABLE 138 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 137
TABLE 139 INDIA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 138
TABLE 140 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 138
TABLE 141 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 139
TABLE 142 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 139
TABLE 143 CHINA: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 140
TABLE 144 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 140
TABLE 145 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 141
TABLE 146 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (USD MILLION) 141
TABLE 147 ROAPAC: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION, 2015–2022 (TONS) 142
TABLE 148 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (USD MILLION) 143
TABLE 149 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE,
2015–2022 (TONS) 144
TABLE 150 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (USD MILLION) 144
TABLE 151 ROW: GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION,
2015–2022 (TONS) 145
TABLE 152 AGREEMENTS, COLLABORATIONS, AND CONTRACTS, 2014–2017 148
TABLE 153 ACQUISITIONS (2014–2017) 150
TABLE 154 APPROVALS, BY COMPANY (2014–2017) 151
TABLE 155 OTHER STRATEGIES (2014–2017) 152

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE 20
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 23
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 23
FIGURE 4 KEY DATA FROM PRIMARY SOURCES 24
FIGURE 5 KEY INSIGHTS FROM INDUSTRY EXPERTS 25
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY 26
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR COLLAGEN MARKET FOR REGENERATIVE MEDICINE 26
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR GELATIN MARKET FOR REGENERATIVE MEDICINE 27
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH FOR GLOBAL COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE 27
FIGURE 10 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH FOR GLOBAL COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE 28
FIGURE 11 RESEARCH DESIGN 28
FIGURE 12 DATA TRIANGULATION METHODOLOGY 29
FIGURE 13 GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE (2017) 31
FIGURE 14 GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE
(2017 VS. 2022) 32
FIGURE 15 GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION (2017 VS. 2022) 33
FIGURE 16 GLOBAL GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION
(2017 VS. 2022) 34
FIGURE 17 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH IN THE COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE DURING THE FORECAST PERIOD 35
FIGURE 18 INCREASING GOVERNMENT AND PRIVATE SUPPORT—MAJOR FACTOR DRIVING THE COLLAGEN MARKET FOR REGENERATIVE MEDICINE 36
FIGURE 19 ASIA-PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 37
FIGURE 20 BOVINE COLLAGEN SEGMENT TO DOMINATE THE GLOBAL COLLAGEN MARKET FOR REGENERATIVE MEDICINE IN 2017 37
FIGURE 21 WOUND CARE SEGMENT WILL CONTINUE TO DOMINATE THE GELATIN MARKET FOR REGENERATIVE MEDICINE IN 2022 38
FIGURE 22 ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 38
FIGURE 23 ASIA-PACIFIC TO WITNESS THE HIGHEST CAGR IN THE FORECAST PERIOD 39
FIGURE 24 DRIVERS, RESTRAINTS, AND OPPORTUNITIES 41
FIGURE 25 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE 46
FIGURE 26 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY SOURCE (2017 VS. 2022) 53
FIGURE 27 COLLAGEN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 59
FIGURE 28 GELATIN MARKET FOR REGENERATIVE MEDICINE, BY APPLICATION 67
FIGURE 29 NORTH AMERICA TO DOMINATE THE COLLAGEN MARKET FOR REGENERATIVE MEDICINE IN 2017 74
FIGURE 30 NORTH AMERICA: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 76
FIGURE 31 EUROPE: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 85
FIGURE 32 ASIA-PACIFIC: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 95
FIGURE 33 REST OF THE WORLD: COLLAGEN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 107
FIGURE 34 NORTH AMERICA TO DOMINATE THE GELATIN MARKET FOR REGENERATIVE MEDICINE IN 2017 111
FIGURE 35 NORTH AMERICA: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 113
FIGURE 36 EUROPE: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 122
FIGURE 37 ASIA-PACIFIC: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 131
FIGURE 38 REST OF THE WORLD: GELATIN MARKET FOR REGENERATIVE MEDICINE SNAPSHOT 143
FIGURE 39 KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE COLLAGEN AND GELATIN MARKET FOR REGENERATIVE MEDICINE (2014–2017) 146
FIGURE 40 BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, AND CONTRACTS FORMED THE KEY GROWTH STRATEGY 147
FIGURE 41 AGREEMENTS, COLLABORATIONS, AND CONTRACTS, BY COMPANY (2014–2017) 148
FIGURE 42 ACQUISITIONS, BY COMPANY (2014-2017) 149
FIGURE 43 APPROVALS, BY COMPANY (2014–2017) 150
FIGURE 44 KEY PLAYERS FOCUSING ON OTHER STRATEGIES, BY COMPANY (2014–2017) 151
FIGURE 45 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT 153
FIGURE 46 COLLAGEN SOLUTIONS PLC: COMPANY SNAPSHOT 158
FIGURE 47 ROYAL DSM: COMPANY SNAPSHOT 161
FIGURE 48 NITTA GELATIN INC.: COMPANY SNAPSHOT (2015) 167

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。